Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas.

Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP.

Clin Exp Immunol. 1996 Aug;105(2):344-52.

4.

Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK.

Duan R, Remeijer L, van Dun JM, Osterhaus AD, Verjans GM.

Invest Ophthalmol Vis Sci. 2007 Jan;48(1):277-84.

PMID:
17197544
5.

Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.

Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H.

Clin Cancer Res. 2003 Oct 1;9(12):4404-8.

6.

Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.

Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP.

Gynecol Obstet Invest. 2001;51(4):254-61.

PMID:
11408737
7.

Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.

Facchetti P, Prigione I, Ghiotto F, Tasso P, Garaventa A, Pistoia V.

Cancer Immunol Immunother. 1996 Mar;42(3):170-8.

PMID:
8640845
8.

Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.

Van den Hove LE, Van Gool SW, Van Poppel H, Baert L, Coorevits L, Van Damme B, Ceuppens JL.

Clin Exp Immunol. 1997 Sep;109(3):501-9.

9.

Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.

Tayebi H, Kuttler F, Saas P, Lienard A, Petracca B, Lapierre V, Ferrand C, Fest T, Cahn J, Blaise D, Kuentz M, Hervé P, Tiberghien P, Robinet E.

Exp Hematol. 2001 Apr;29(4):458-70.

PMID:
11301186
10.

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.

Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.

Pediatrics. 2006 May;117(5):e878-86.

PMID:
16618789
11.

Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.

Wong PY, Staren ED, Tereshkova N, Braun DP.

J Surg Res. 1998 Apr;76(1):95-103.

PMID:
9695747
12.

Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.

Belldegrun A, Tso CL, Kaboo R, Pang S, Pierce W, deKernion JB, Figlin R.

J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):149-61.

PMID:
8732698
13.

Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.

Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.

Cancer Res. 2001 Nov 1;61(21):7925-33.

14.

Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.

Mulders P, Tso CL, Gitlitz B, Kaboo R, Hinkel A, Frand S, Kiertscher S, Roth MD, deKernion J, Figlin R, Belldegrun A.

Clin Cancer Res. 1999 Feb;5(2):445-54.

15.
16.

Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Halapi E, Yamamoto Y, Juhlin C, Jeddi-Tehrani M, Grunewald J, Andersson R, Hising C, Masucci G, Mellstedt H, Kiessling R.

Cancer Immunol Immunother. 1993;36(3):191-7.

PMID:
8439980
17.

In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.

Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.

Clin Cancer Res. 1997 Apr;3(4):633-43.

18.

Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes.

DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK.

Cancer Immunol Immunother. 1996 Sep;43(1):49-58.

19.

Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.

Rayman P, Uzzo RG, Kolenko V, Bloom T, Cathcart MK, Molto L, Novick AC, Bukowski RM, Hamilton T, Finke JH.

Cancer J Sci Am. 2000 Feb;6 Suppl 1:S81-7.

PMID:
10685665
20.

Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.

Waziri A, Killory B, Ogden AT 3rd, Canoll P, Anderson RC, Kent SC, Anderson DE, Bruce JN.

J Immunol. 2008 Jun 1;180(11):7673-80.

Items per page

Supplemental Content

Support Center